ArticleNature biotechnology2013
Staying on target with CRISPR-Cas.
Article in Nature biotechnology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Versatile generation of precise gene edits in bovines using SEGCPN.BMC biology · 2023Article
- CRISPR/Cas-mediated genome editing in mice for the development of drug delivery mechanism.Molecular biology reports · 2023Review
- Precise genome engineering inProceedings of the National Academy of Sciences of the United States of America · 2021Article
- Plant Genome Editing and the Relevance of Off-Target Changes.Plant physiology · 2020Article
- Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors.Molecular therapy : the journal of the American Society of Gene Therapy · 2019Article
- Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.Plant molecular biology · 2018Article
- A review on advanced methods in plant gene targeting.Journal, genetic engineering & biotechnology · 2017Review
- Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1.Molecular therapy. Nucleic acids · 2017Article
- The Chromatin Structure Differentially Impacts High-Specificity CRISPR-Cas9 Nuclease Strategies.Molecular therapy. Nucleic acids · 2017Article
- Heritability of targeted gene modifications induced by plant-optimized CRISPR systems.Cellular and molecular life sciences : CMLS · 2017Review
- Lessons from Enzyme Kinetics Reveal Specificity Principles for RNA-Guided Nucleases in RNA Interference and CRISPR-Based Genome Editing.Cell systems · 2017Review
- CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2016Article
- Origins of Programmable Nucleases for Genome Engineering.Journal of molecular biology · 2016Review
- The Rise of CRISPR/Cas for Genome Editing in Stem Cells.Stem cells international · 2016Review
- Mapping the precision of genome editing.Nature biotechnology · 2015Article
- Strategies for precision modulation of gene expression by epigenome editing: an overview.Epigenetics & chromatin · 2015Review
- Making designer mutants in model organisms.Development (Cambridge, England) · 2014Review
- Efficient gene editing in tomato in the first generation using the clustered regularly interspaced short palindromic repeats/CRISPR-associated9 system.Plant physiology · 2014Article
- Application of TALEs, CRISPR/Cas and sRNAs as trans-acting regulators in prokaryotes.Current opinion in biotechnology · 2014Review
- Targeted genome editing in Aedes aegypti using TALENs.Methods (San Diego, Calif.) · 2014Article
Corrections and comments
- Comment on
- Comment on
- Comment on
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24022156What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.